Category: News
-
Atuka releases its latest white paper, on the future of gene therapy
—
Building on Atuka’s pioneering work in Parkinson’s disease and other neurodegenerative disorders, this paper lays out the transformative potential of gene therapy.
-
Announcing a $1.5m collaboration with Kannalife Sciences and Michael J. Fox Foundation
—
The grant will fund preclinical research of Kannalife Science’s KLS-13019, a synthetic cannabinoid therapeutic which offers great promise for Parkinson’s disease.
-
Atuka welcomes new board member Ian Lennox
—
As Atuka expands beyond its traditional base in Parkinson’s research, we look forward to Lennox’s contributions as a pioneering executive with decades of experience as an innovator in our sector.